Novel Insights and Therapeutics for Parkinson’s disease

Parkinson’s disease is the essential growth driver of the worldwide Parkinsons disease therapeutics. Most mutations such as SNCA, PINK1, PARK2, PARK7, PLA2G6, FBXO7 and ATP13A2 are the rare cause of the disease and one particular mutation in LRRK2 has been found common in certain populations. The enzymatic function of the mitochondrial localized kinase PINK1 is thereby essential and delivers a fast production of Parkin from its uniform distribution in the cytoplasm to damaged mitochondria. Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The therapeutics of Parkinsons Disease includes designing a Clinical trial for Parkinson, Outcome of clinical trials in PSP, therapeutic options for mood, Cognition and Psychosis. Physical therapy cannot cure Parkinson’s disease but therapy can help to compensate the changes brought about by the condition, physical therapy can help with balance problems, fatigue, pain, weakness and sometimes local heat application is produced with high frequency to relieve muscle aches and pain.


  • Levodopa
  • Clinical trial for Parkinson,
  • Outcome of clinical trials in PSP
  • Therapeutic options for mood
  • Cognition and Psychosis

Related Conference of Novel Insights and Therapeutics for Parkinson’s disease

January 27-28, 2025

10th World Congress on Public Health and Nutrition

Bangkok, Thailand
February 24-25, 2025

21st Global Congress on Healthcare and Technologies

Madrid, Spain
March 17-18, 2025

5th International conference on Healthcare Summit

Singapore City, Singapore
March 27-28, 2025

7th International Conference on Digital Health

London, UK
April 07-08, 2025

7th World Summit on Women's Health and Cancer Awareness

Vancouver, Canada
April 24-25, 2025

4th International Congress on Global Healthcare

Vienna, Austria
May 14-15, 2025

7th World Conference on Vaccine and Immunology

Barcelona, Spain
May 22-23, 2025

International Congress on Primary Health and Safety

Toronto, Canada
July 23-24, 2025

30th International Conference on Skincare and Cosmetology

Amsterdam, Netherlands
July 24-25, 2025

36th European Heart and Heart Failure Congress

Paris, France
September 15-16, 2025

15th International Conference on Preventive Medicine & Public Health

Aix-en-Provence, France
September 22-23, 2025

21st Global Biomarkers and Clinical Research Summit

Paris, France
September 25-26, 2025

3rd International Conference on Oral Health and Dentistry

Zurich, Switzerland
October 30-31, 2025

6th International Conferences in COPD & Lung Disease

Paris, France
November 13-14, 2025

5th Euro-Global Summit on Probiotics & Nutraceuticals

Aix-en-Provence, France
November 24-25, 2025

4th Global Conference on Aging and Gerontology

Barcelona, Spain

Novel Insights and Therapeutics for Parkinson’s disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in